A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/20/2011	US20110257364 Process for purifying glycopeptide phosphonate derivatives
10/20/2011	US20110257107 Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria
10/20/2011	US20110257106 Polymer Stabilized Neuropeptides
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257104 Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor
10/20/2011	US20110257103 Compositions and methods for the treatment of sj?rgren's syndrome
10/20/2011	US20110257102 Compositions and methods of treating cancer
10/20/2011	US20110257101 Catecholamine regulated protein
10/20/2011	US20110257100 Inhibitors of Protein Tyrosine Kinase Activity
10/20/2011	US20110257099 Use of Natriuretic Peptide for Treating Heart Failure
10/20/2011	US20110257098 Compositions and methods for treating growth hormone deficiency
10/20/2011	US20110257097 Pharmaceutical compositions of somatotrophic hormones
10/20/2011	US20110257096 Compositions for drug administration
10/20/2011	US20110257095 Pharmaceutical compositions and related methods of delivery
10/20/2011	US20110257094 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
10/20/2011	US20110257093 Therapies for acute renal failure
10/20/2011	US20110257092 Glucagon/glp-1 receptor co-agonists
10/20/2011	US20110257091 Insulin analogs
10/20/2011	US20110257090 Solutions for volume therapy
10/20/2011	US20110257089 Liquid high-fat protein composition
10/20/2011	US20110257088 Low-Concentration Nutritional Composition
10/20/2011	US20110257087 Protein Hydrolysate Compositions Having Enhanced CCK Releasing Activity
10/20/2011	US20110257086 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110257084 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same
10/20/2011	US20110257083 Msp-1 protein preparations from plasmodium
10/20/2011	US20110257082 Hiv-1 integrase derived stimulatory peptides interfering with integrase -- rev protein binding
10/20/2011	US20110257081 Multigand constructs
10/20/2011	US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011	US20110257079 Parenteral Combination Therapy for Infective Conditions With Drug Resistant Bacterium
10/20/2011	US20110257078 Antibacterial combination therapy for the treatment of gram positive bacterial infections
10/20/2011	US20110257077 Compounds and compositions as channel activating protease inhibitors
10/20/2011	US20110257076 Amide based insulin prodrugs
10/20/2011	US20110257075 Guanidino acetic acid used as an animal food additive
10/20/2011	US20110257074 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation
10/20/2011	US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex
10/20/2011	US20110256260 Methods and compositions for synthesis of long chain polyunsaturatd fatty acids
10/20/2011	US20110256247 Topical compositions containing nitro fatty acids
10/20/2011	US20110256239 Ingestible hair and finger nail growth promoter and method
10/20/2011	US20110256235 Compositions and methods relating to prevention of chemotherapy-induced alopecia
10/20/2011	US20110256225 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256213 Phospholipid micellar and liposomal compositions and uses thereof
10/20/2011	US20110256204 Rapid preparation and use of engineered tissue and scaffolds as individual implants
10/20/2011	US20110256203 Porous ceramic scaffold having an organic/inorganic hybrid coating layer containing bioactive factor and method thereof
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256163 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256152 Methods Of Treating And Preventing Glucose Toxicity
10/20/2011	US20110256150 Modulation of Axon Degeneration
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256136 Complement Inhibitors For Treatment Of Injury From Intracerebral Hemorrhage
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256120 Methods and Compositions for Reducing Amyloid Beta Levels
10/20/2011	US20110256119 Novel uses of grs proteins or fragments thereof
10/20/2011	US20110256118 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256113 Method for preventing and treating diabetes using neurturin
10/20/2011	US20110256106 Methods and Compositions for Treating Intervertebral Disc Degeneration
10/20/2011	US20110256105 Cardiac stem cell and myocyte secreted paracrine factors
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256100 Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signaling
10/20/2011	US20110256099 Compounds for the Treatment of Hepatitis C
10/20/2011	US20110256098 Immunotherapy for chronic hepatitis c virus infection
10/20/2011	US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
10/20/2011	US20110256096 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
10/20/2011	US20110256095 Tissue Matrix System
10/20/2011	US20110256094 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
10/20/2011	US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity
10/20/2011	US20110256092 Quinoline derivatives for modulating dna methylation
10/20/2011	US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof
10/20/2011	US20110256089 Hydrogel Type Cell Delivery Vehicle for Wound Healing, and Preparation Method Thereof
10/20/2011	US20110256088 Targeted delivery of nucleic acids
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110256063 Mex3c regulation and target to control obesity and diabetes
10/20/2011	US20110256058 Novel Peptides and Uses Thereof
10/20/2011	US20110256057 Cyclic Azapeptides as Integrin Markers and Methods of Using
10/20/2011	DE102010015815A1 Use of glucose isomerase in therapy or diagnosis of diabetes and metabolic syndrome, preferably insulin resistance syndrome, and as food product, preferably dietary food, a dietary supplement or a food additive
10/20/2011	CA2796336A1 Methods for treating glucose metabolic disorders
10/20/2011	CA2796303A1 Robo1-fc fusion protein and use thereof for treating tumours
10/20/2011	CA2796205A1 Combination treatment with vegf-c antagonists
10/20/2011	CA2796175A1 Capping-prone rna polymerase enzymes and their applications
10/20/2011	CA2796010A1 Trail r2-specific multimeric scaffolds
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/19/2011	EP2378288A1 Unnatural reactive amino acid genetic code additions
10/19/2011	EP2377938A1 Capping-prone RNA polymerase enzymes and their applications
10/19/2011	EP2377884A1 Neuritogenic peptides
10/19/2011	EP2377880A2 Combination therapy of HIV fusion entry inhibitors targeting gp41
10/19/2011	EP2377878A1 Potent compstatin analogs
10/19/2011	EP2377877A1 Potent compstatin analogs
10/19/2011	EP2377876A1 Use of proteins and peptides of the TGF-BETA superfamily for purification and therapeutic methods
10/19/2011	EP2377579A1 Cyclic peptide CXCR4 antagonists
10/19/2011	EP2377549A1 Use of IL-21 for treating viral infections
10/19/2011	EP2377548A2 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
10/19/2011	EP2377547A1 Use of IL-21 as an antimicrobial agent
10/19/2011	EP2377546A2 Compositions and methods for promoting wound healing and tissue regeneration

1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 3163